Hillsdale Investment Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-37,400	Closed	-$607K	–	585
2020 Q1	$607K	Sell	37,400 -9,000	-19%	-$146K	0.07%	251
2019 Q4	$835K	Buy	+46,400	New	+$835K	0.07%	249